Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
13.83%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 3.44Close
$ 1.06 - $ 6.77 52-Week Range
Ticker Information
Ticker
CPIXCompany Name
CUMBERLAND PHARMACEUTICALS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQCUMBERLAND PHARMACEUTICALS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CPIX - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 5.82M | 13.83% | $ 42.07M |
| 3/31/2025 | $ 5.92M | 14.42% | $ 41.08M |
| 12/31/2024 | $ 6.04M | 15.96% | $ 37.87M |
| 9/30/2024 | $ 6.33M | 17.21% | $ 36.79M |
| 6/30/2024 | $ 6.17M | 16.34% | $ 37.79M |
| 3/31/2024 | $ 5.95M | 15.33% | $ 38.83M |
| 12/31/2023 | $ 5.77M | 14.59% | $ 39.55M |
| 9/30/2023 | $ 4.21M | 10.72% | $ 39.32M |
| 6/30/2023 | $ 4.51M | 11.1% | $ 40.65M |
| 3/31/2023 | $ 4.93M | 12.31% | $ 40.06M |
Key Performance Insights, Last 5 Years
- CUMBERLAND PHARMACEUTICALS INC's latest trailing twelve months (TTM) DepAmor % stands at 11.38%.
- Over the past 5 years, CUMBERLAND PHARMACEUTICALS INC's average DepAmor % has been 13.54%.
- The median DepAmor % for CUMBERLAND PHARMACEUTICALS INC during this period was 13.27%
- CUMBERLAND PHARMACEUTICALS INC reached its highest DepAmor % over the past 5 years at 17.21%.
- The lowest DepAmor % recorded by CUMBERLAND PHARMACEUTICALS INC in the same timeframe 10.72%
CUMBERLAND PHARMACEUTICALS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for CUMBERLAND PHARMACEUTICALS INC is calculated as follows: DepAmor [ $ 4.65M ] / Revenues [ $ 40.86M ]
(=) DepAmor % [ 11.38% ] CPIX - Depreciation and Amortization Margin, Last 5 years
10.72%
Minimum
Sep 30, 2023
17.21%
Maximum
Sep 30, 2024
13.54%
Average
13.27%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |